Colin Sainsbury

Colin Sainsbury has extensive experience in international transactions and equity investments in Ireland. Colin is widely recognised as a leading expert in the life sciences, medical device and technology sectors. Colin's clients include a broad range of companies operating in the life sciences and related sectors including biotechnology, pharmaceutical and med tech companies, research institutions and government institutions such as: Alimentary Health, Alkermes, Apica Cardiovascular, Azur Pharma, Biogen-Idec, DCU, Elan Corporation, i360, GenCell Biosystems, Jazz Pharma (Azur Pharma), Merrion Pharmaceuticals, NUI Galway, Ovagen Limited, Proxy Biomedical, Quintiles, Q3 Medical Devices Limited, Shire Pharmaceuticals, Shionogi.

Colin also acts for a number of companies in the Food and Beverage Sectors who are increasingly becoming involved in intellectual property based transactions and related financings.

Colin is an active member of the Licensing Executives Society Laws Committee (Britain and Ireland) and the Irish American Chamber of Commerce Research & Development Committee (which has engaged with a number of state agencies). For four years Colin was a member of the Business Law Committee of the Law Society of Ireland.